Compounds > 2-amino-1,3,4-thiadiazole
Page last updated: 2024-08-22

2-amino-1,3,4-thiadiazole and Lung Neoplasms

2-amino-1,3,4-thiadiazole has been researched along with Lung Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albrecht, J; Juszczak, M; Matysiak, J; Niewiadomy, A; Pożarowski, P; Rzeski, W; Szeliga, M1
Ackerly, CC; Krakoff, IH; Myers, CF; Newman, RA; Stewart, JA1
Blough, R; Cobleigh, M; Johnson, C; Krauss, S; Kukla, L; Lad, T; Lanzotti, V; McGuire, WP; Shevrin, DH1

Other Studies

3 other study(ies) available for 2-amino-1,3,4-thiadiazole and Lung Neoplasms

ArticleYear
2-Amino-1,3,4-thiadiazole derivative (FABT) inhibits the extracellular signal-regulated kinase pathway and induces cell cycle arrest in human non-small lung carcinoma cells.
    Bioorganic & medicinal chemistry letters, 2012, Sep-01, Volume: 22, Issue:17

    Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p27; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; MAP Kinase Signaling System; Models, Molecular; Thiadiazoles

2012
Clinical and clinical pharmacologic studies of 2-amino-1,3,4-thiadiazole (A-TDA:NSC 4728).
    Cancer chemotherapy and pharmacology, 1986, Volume: 16, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Drug Eruptions; Drug Evaluation; Female; Half-Life; Humans; Kinetics; Lung Neoplasms; Male; Middle Aged; Stomatitis; Thiadiazoles; Uric Acid

1986
Phase II trial of aminothiadiazole in advanced non-small cell lung cancer.
    Cancer treatment reports, 1986, Volume: 70, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Thiadiazoles

1986